Delivery Order SPE2DB22D9239-SPE2DB23FDD68
Award Date 10/13/22
Potential Completion Date 11/3/22
Potential Value $227K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide Entyvio 300 mg vials. The $39,429.44 award has a completion date of January 30, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds various federal contracts to supply pharmaceuticals and medical products to the Department of Defense. This delivery order is issued against DMS Pharmaceutical Group's existing...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 300 mg vials of the drug Entyvio. The delivery order, valued at $141,773.70, has a completion date of November 21, 2022. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds various federal contracts and indefinite delivery vehicles (IDVs) to supply pharmaceuticals and medical products to military treatment facilities...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide Entyvio 300 mg vials. The order is valued at $96,245.20 and has a performance period through January 17, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds multiple contracts and indefinite delivery vehicles (IDVs) with DLA Troop Support Medical to supply a variety of pharmaceutical and medical products in support of...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide Entyvio 300 mg vials. The $98,573.60 contract has a completion date of February 15, 2024. DMS Pharmaceutical Group is an experienced pharmaceutical wholesaler that holds an indefinite delivery contract with the Defense Logistics Agency, enabling the agency to issue delivery orders for a wide range of medical supplies...
- The Defense Logistics Agency awarded a firm fixed price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 300 mg vials of the pharmaceutical product Entyvio. The contract has a potential value of $226,837.92 and a completion date of September 28, 2022. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds multiple federal contracts and indefinite delivery vehicles (IDVs) with the Defense Logistics Agency to supply a variety of...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the pharmaceutical product Entyvio 300 mg vials. The delivery order, valued at $113,418.96, was issued under an existing indefinite delivery contract with DLA to supply various medical supplies and pharmaceuticals to military treatment facilities worldwide. DMS Pharmaceutical Group holds numerous federal contracts and blanket purchase...
- The Defense Logistics Agency awarded a delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 300 milligram vials of the pharmaceutical drug Entyvio. The firm fixed price contract has a potential value of $144,367.80 and a completion date of February 27, 2023. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds a variety of federal contracts to supply pharmaceuticals and medical products to the Department of Defense and...
- The Defense Logistics Agency awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 300 mg vials of the pharmaceutical product Entyvio. The award has a potential value of $141,773.70 and a completion date of September 16, 2022. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds multiple federal contracts and indefinite delivery vehicles to supply a wide range of pharmaceutical and medical products to support...
- The U.S. Defense Logistics Agency awarded a firm fixed price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business. The $144,367.80 contract is for the supply of Entyvio 300 mg vials, a pharmaceutical product, with a completion date of March 24, 2023. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that provides a wide range of brand and generic prescription and over-the-counter drugs to the federal government, primarily the Department of Defense,...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $48,122.70 by the Defense Logistics Agency to provide 4562986926 units of Entyvio 300 mg vials. The delivery order was awarded on November 30, 2023 under DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency to supply pharmaceuticals and medical supplies with a potential value of up to $5 million through December 2025. As a woman-owned small business and pharmaceutical...
- SPE2DB22D9239Indefinite Delivery Contract
- SPE2DB22D9239-SPE2DB23FDD68Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the pharmaceutical product Entyvio 300 mg vials. The $226,837.92 award has a completion date of November 3, 2022. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds various federal contracts and indefinite delivery vehicles with DLA to supply pharmaceuticals and medical products in support of military treatment facilities worldwide.
Generated 3/23/24, 2:22 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $226.8k | 10/13/22 |